Cutaneous Kaposi's Sarcoma

Yun Liu,Lindi Jiang

DOI: https://doi.org/10.1136/bmj.n926

2021-01-01

Abstract:This is iatrogenic Kaposi’s sarcoma associated with human herpesvirus 8 on the leg of a woman in her 60s (fig 1). Fig 1 One year earlier she had received a diagnosis of dermatomyositis, an …

What problem does this paper attempt to address?

Kaposi’s Sarcoma Manifested As Lower Gastrointestinal Bleeding in a HIV/HBV-co-infected Liver Cirrhosis Patient: A Case Report

Qi-Hui Zhou,Yong-Zheng Guo,Xia-Hong Dai,Biao Zhu

DOI: https://doi.org/10.12998/wjcc.v7.i19.3090

2019-01-01

World Journal of Clinical Cases

Abstract:BACKGROUND Kaposi's sarcoma (KS) is one of the most common cancers in human immunodeficiency virus (HIV)-positive patients and leads to a high prevalence of morbidity and mortality. It usually appears as cutaneous or mucous lesions. Patients with visceral KS are asymptomatic and clinically silent. As the disease advances, patients may progress from a normal condition to exhibiting severe symptoms. CASE SUMMARY A 27-year-old man presented with a 2-mo history of fever, bearing-down pain, and rectal bleeding. His hepatitis B virus DNA level was 2.7x10(7) IU/mL. Abdominal computed tomography (CT) indicated liver cirrhosis. Before he was admitted to our hospital, he was diagnosed with HIV infection. His CD4 count was 24 cells/mu L. Pelvic cavity CT suggested a thickened rectum wall accompanied by multiple enlarged lymph nodes. The patient was initially treated as having haemorrhoidal varices with bleeding, telbivudine for anti-hepatitis B virus treatment, and antibiotics for anti-infection. After half a month of treatment, the patient felt that his lower lumbus ache and bearing-down pain had not improved, and a colonoscopy was conducted. The result revealed a rectal mass that was histologically confirmed as KS with rectal spindle cells that were positive for cluster of differentiation 117 (CD117), CD34, human herpes virus 8, and CD31. He was administered systemic chemotherapy with 36 mg/d liposomal doxorubicin six times. The patient experienced no sign of lower gastrointestinal bleeding again. CONCLUSION This case highlights the diagnosis of primary KS with lower gastrointestinal bleeding in HIV-positive patients, which means visceral KS could not be excluded. The gold standard relies on colonoscopy and biopsy findings.
Vaccine prospect of Kaposi sarcoma-associated herpesvirus.

Ting-Ting Wu,Jing Qian,Jian Ang,Ren Sun

DOI: https://doi.org/10.1016/j.coviro.2012.06.005

IF: 7.121

2012-01-01

Current Opinion in Virology

Abstract:Infection of Kaposi sarcoma-associated herpesvirus (KSHV) or human herpesvirus-8 (HHV-8) is estimated to account for 34,000 new cancer cases globally. Unlike other herpesviruses, KSHV is not ubiquitous but is highly prevalent in some areas, such as sub-Saharan Africa where Kaposi sarcoma is the leading cancer among adults. While latent infection of KSHV plays a major and direct role in tumorigenesis, viral lytic replication also makes significant contributions to this process. Efforts to develop a KSHV vaccine are limited, but studies with EBV have provided important lessons. Informative vaccine research has been conducted in the mouse infection model of a closely related rodent virus, murine gammaherpesvirus-68 (MHV-68 or γHV-68). This mouse model has generated fundamental principles for an effective vaccination strategy. KSHV vaccines designed to prevent a naïve host from infection and to boost the immune control of KSHV in persistently infected people will have major impact on individuals who are at a high risk of developing KSHV-associated diseases.
[Kaposi's disease: an unusual side-effect of topical corticosteroids]

H Boudhir,M Mael-Ainin,K Senouci,B Hassam,L Benzekri

DOI: https://doi.org/10.1016/j.annder.2013.04.078

Abstract:Background: Kaposi's sarcoma is an angiogenic tumour associated with HHV8 infection. There are several clinical forms, including those related to acquired immunosuppression. We report a case of nodular lesions in Kaposi's disease that appeared during treatment of bullous pemphigoid with topical corticosteroids. Patients and methods: A 74-year-old female patient presented bullous pemphigoid lesions on all four limbs that were treated with clobetasol cream, a topical corticosteroid. After 2 months of treatment, the patient noted the appearance of several asymptomatic purple, erythematous, papulonodular lesions of elastic consistency on her right thigh and both legs. The histological examination revealed Kaposi's disease with positive immunolabelling for HHV8 in the tumour cells. HIV serology was negative. The lesions disappeared 4 months after cessation of corticosteroid therapy and the patient was still in remission one year later. Comment: Authentic "Mediterranean" cutaneous Kaposi's disease was apparently revealed in this patient during treatment with extremely potent topical corticosteroids, before regressing completely on discontinuation of the medication. We discuss the various mechanisms that could have contributed to this side-effect of dermal corticosteroids, whose sustained application over a wide area caused HHV8 antigen reactivation.
Kaposi Sarcoma Combined with Severe Ulcerative Colitis: A Case Report and Literature Review

J Li,Z Y Niu,Y Xue,X Y Shi,B Zhang,Y Wang

DOI: https://doi.org/10.19723/j.issn.1671-167x.2020.02.028

2020-01-01

Abstract:Kaposi's sarcoma (KS) is an unusual vascular tumor associated with human herpesvirus-8 (HHV-8) infection, which is common in immunosuppressors. Although extremely rare, iatrogenic (drug-related) KS can occur in human immunodeficiency virus (HIV)-negative patients under immunosuppressive therapy. We report a 64-year-old male diagnosed with ulcerative colitis for 1 year. He was treated with methylprednisolone because of an acute severe disease flare. He presented with several popular violet lesions on the body 4 months after steroid therapy. Histological examination of skin biopsies showed Kaposi's sarcoma associated with HHV-8. The skin lesions regressed after steroid withdrawal and chemotherapy. Two key words "Kaposi's sarcoma" and "inflammatory bowel disease" were searched in Wanfang data and CNKI, but no relevant articles were found. Thirty-eight articles in English were retrieved on PubMed with the key words of ("ulcerative colitis" OR "Crohn's disease" OR "inflammatory bowel disease") AND (Kaposi sarcoma). Twenty-five cases of Kaposi's sarcoma related to inflammatory bowel disease (IBD) were reported. Including this case, the majority of 26 Kaposi's sarcoma related IBD patients were male (80.8%, 21/26). The average age was (51.1 ± 16.4) years. Twenty cases were ulcerative colitis and 6 were Crohn's disease. All the patients received immunomodulatory therapy, including glucocorticoid, azathioprine/mercaptopurine, methotrexate, cyclosporin and anti tumor necrosis factor α antibody. Thirteen cases were positive for HHV-8. There were 18 cases involving the distal ileum and colorectum only, 3 cases involving skin only, and 5 cases involving both skin and colorectum at the same time. Overall, the prognosis was good. Three patients only stopped immunosuppressive therapy, 1 received radiotherapy, 1 received chemotherapy, and 20 received surgery. Kaposi's sarcoma could be seen in IBD patients with immunomodulatory therapy. It is very important to distinguish from the skin lesions related to IBD or drug treatment. The adverse reactions of immunomodulatory therapy should not be ignored. In addition, attention should be paid to the cooperation of multi-disciplinary team, which can diagnose and treat rare cases earlier and more accurately.
Sign of Leser-Trélat Associated with Kaposi Sar-coma in an Immunocompetent Man

Hershel E Dobkin,Juan P Estrada,Allen Sapadin,Nardin Awad

2024-08-02

SKINmed

Abstract:A 68-year-old Latino man presented at our clinic with asymptomatic, indurated red nodules and macules of 2-month duration on the left arm, forearm, and palm (Figure 1). Performed punch biopsy presented characteristic -features of Kaposi sarcoma (KS). Immunohistochemistry was positive for human herpesvirus 8 (HHV8), a highly correlated viral marker, confirming the diagnosis of KS (Figure 2). He was referred to oncology for further management, where he was found to be fully immunocompetent with a negative assessment of human immunodefi-ciency virus (HIV). Computed tomography (CT) performed of his chest and abdomen revealed no involvement of internal organs.
Pulmonary Kaposi Sarcoma in the Era of Antiretroviral Therapy: A Case Series

Michael Alexander Pelidis,Lefika Bathobakae,Arielle Aiken,Katrina Villegas,Malina Mohtadi,Abraam Rezkalla,Nargis Mateen,Hussein Mhanna,Medhat Ismail,Patrick Michael

DOI: https://doi.org/10.14740/jmc4251

Abstract:Kaposi sarcoma (KS) is an angioproliferative neoplasm that affects the skin and lymph nodes. Human herpesvirus-8 (HHV-8) triggers KS by infecting the endothelium and inducing angiogenesis through the production of vascular endothelial growth factors and cytokines. KS is characterized by purplish or hyperpigmented plaques involving the skin and mucous membranes, and visceral involvement is very rare. Pulmonary KS (PKS) is an exceedingly rare visceral manifestation of KS and has a poor prognosis. PKS often presents with cough, hemoptysis, pleuritic chest pain, fever, and weight loss. In this case series, we share our experience in diagnosing and treating two patients with PKS. We also provide a concise review of the epidemiology, signs and symptoms, diagnosis, and management of this rare condition.
Endoscopic Appearance of Oropharyngeal and Upper GI Kaposi's Sarcoma in an Immunocompromised Patient

Umar Darr,Anas Renno,Zubair Khan,Turki Alkully,Maitham A Moslim,Sehrish Kamal,Ali Nawras

DOI: https://doi.org/10.1155/2017/3742684

Abstract:Introduction. Kaposi's sarcoma (KS) usually manifests as a cutaneous disease but GI manifestation is often rare. It is associated with human herpes virus-8 (HHV-8) and seen in immunocompromised patients. In the USA, use of highly active antiretroviral therapy (HAART) has drastically reduced incidence of KS in HIV patients. Case Presentation. A 65-year-old male with human immunodeficiency virus (HIV) was admitted to the intensive care unit (ICU) with cardiopulmonary arrest secondary to hyperkalemia of 7.5 meq/L. Following placement of orogastric and endotracheal tube (ETT), a significant amount of blood was noticed in the ETT. Hemoglobin trended down from 9.6 mg/dL to 6.7 mg/dL over five days. Stool guaiac was positive. Esophagogastroduodenoscopy (EGD) was performed and revealed multiple large hypervascularized violaceous submucosal nodular lesions with stigmata of bleeding seen on the soft palate and pharynx and within the cricopharyngeal area close to the vocal cords. Biopsy of the soft palate lesions showed proliferation of neoplastic spindle shaped cells arranged in bundles with slit-like capillary spaces containing erythrocytes consistent with Kaposi's sarcoma. Biopsy was positive for HHV-8. Colonoscopy was unremarkable. There were no cutaneous manifestations of the disease. Conclusion. GI involvement of Kaposi's sarcoma must be considered in immunocompromised patients and can be confirmed by endoscopic methods.
Kaposi's sarcoma and its associated herpesvirus

Enrique A. Mesri,Ethel Cesarman,Chris Boshoff

DOI: https://doi.org/10.1038/nrc2888

IF: 78.5

2010-09-24

Nature Reviews Cancer

Abstract:Key PointsKaposi's sarcoma herpesvirus (KSHV; also known as human herpesvirus 8 (HHV8)) is the causative agent of Kaposi's sarcoma (KS) and certain lymphoproliferations, and its seroepidemiology correlates with the global incidence of KS.KS is the most common neoplasm in untreated HIV-infected individuals, and also occurs in other states of immunosuppression, including after an organ transplant.KSHV is transmitted through saliva and replicates in oropharyngeal cells.Unlike most cancer cells, KS tumour cells are not fully transformed, do not show autonomous growth, and remain dependent on exogenous cytokines for in vitro growth.KS starts as a proliferation of endothelial-type cells, with an early onset inflammatory and abnormal leaky blood vessel expansion.KSHV is present in the vast majority of KS tumour cells (that is, spindle cells), expressing the latent viral proteins, including viral cyclin, viral FLICE inhibitory protein, latency-associated nuclear antigen (LANA) and a group of viral microRNAs.A proportion of cells in KS lesions seem to undergo lytic replication, expressing lytic viral proteins including K1, viral interleukin-6, viral BCL-2, viral G protein-coupled receptor, K15 and viral chemokines.KSHV latent genes drive cell proliferation and prevent apoptosis; whereas KSHV lytic genes could further contribute to KS tumorigenesis by triggering host signalling cascades that lead to cytokine and growth factor secretion.Biological insights into KSHV oncogenesis are leading to promising rational therapeutic approaches.

oncology
Kaposi Sarcoma after Kidney Transplantation: a Case Report and Literature Review

Li Kun,Wang Zhiming,Zhang Zhen,Wang Kai,Wang Guangjian,Guo Fengfu

DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2018.10.007

2018-01-01

Abstract:Objective To investigate the epidemiology,clinical features,etiology and treatment of Kaposi sarcoma after kidney transplantation through the diagnosis and treatment of a patient with Kaposi sarcoma after kidney transplantation.Methods The clinical data of a 61-year-old man with Kaposi sarcoma who had kidney transplantation in 2015 were retrospectively analyzed,and the relevant leteratures at home and abroad were reviewed.The patient was an elderly male who underwent renal allograft transplantation for end-stage uremia,and the operation was successful.Preoperative detection of antibodies such as EB virus were negative.Besides,the donor donated organs after the death of the citizen (donation after cardiac death).The man developed dark brown plaques on the outside of his right lower leg and had a roundish-purple tumor on his left ear at the end of 3 months after kidney transplantation,gradually increasing without any other special discomfort.After admission,relevant examinations showed that the function of the transplanted kidney was stable and no other related lesions were found.HIV confirmatory test was negative and the pathology was consistent with Kaposi sarcoma.Therefore,the diagnosis was Kaposi sarcoma and kidney transplantation status.Results Then,the treatment was modified.The cyclosporine +mycophenolate mofetil + prednisone triple immunosuppressive regimen was discontinued and the immunosuppressive drug was changed to sirolimus at a concentration of about 5.69 ng/mL.After treatment for half a year,the Kaposi sarcoma disappeared gradually.Furthermore,the graft function was still stable and up to now,no recurrence of Kaposi sarcoma has been observed.Conclusion Though characteristics of skin lesion are helpful,confirmed diagnosis relies on pathology.And sirolimus may be effective in the treatment of Kaposi sarcoma after kidney transplantation.
Classic Kaposi Sarcoma in an Immunocompetent Male From Haiti: An Unusual Epidemiological Presentation

Emanuel Vanegas,Aye M Thida,Edward Heilman,Mohan Preet

DOI: https://doi.org/10.7759/cureus.64518

2024-07-14

Cureus

Abstract:Kaposi sarcoma (KS) is an angioproliferative disorder caused by human herpesvirus-8 (HHV-8) infection. KS manifests as vascular and mucosal nodules and is classified into four subtypes based on epidemiology, clinical presentation, histopathology, and HHV-8/human immunodeficiency virus serology. Here, we present a unique case of classic KS in an 84-year-old immunocompetent Haitian male patient, highlighting the rarity of this variant in this population. Additionally, our article delves into the broader context by reviewing a few documented cases of classic KS in the Caribbean region.
Hiv Diagnosis Due To Kaposi ́S Sarcoma Lesion In The Oral Cavity: Case Report.

Kariana Wan Dall GONÇALVES,Giovana Frech MULEZINI,Aaaron Bensaul Trujillo LOPEZ,Leticia Aparecida CUNICO,João Paulo Stanislovicz PROHNY,Juliana Lucena SCHUSSEL,Laurindo Moacir SASSI

DOI: https://doi.org/10.1016/j.oooo.2023.12.492

2024-06-07

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Abstract:Kaposi's sarcoma (KS) is a tumor linked to human herpesvirus 8 (KSHV/HHV8) infection and acquired immunodeficiency syndrome (AIDS/HIV). The objective of this study is to report a case involving an HIV-positive patient with a Kaposi's Sarcoma lesion in the oral cavity. A 33-year-old male patient presented with significant weight loss and an exophytic, pedunculated, purplish lesion measuring 5cm in the anterior maxilla, which was progressively growing. The histopathological examination revealed papillomatous hyperplasia of squamous mucosa with persistent hemangiomatous and intense stromal hemorrhage, and blood tests confirmed HIV positivity.

dentistry, oral surgery & medicine
Skin nodules in a young patient with HIV/AIDS

Hamza Hashmi,Jonathan Struan Alexander

DOI: https://doi.org/10.1136/bcr-2019-231096

2019-09-18

Abstract:AIDS-related Kaposi sarcoma (KS) is a malignancy seen in patients with HIV/AIDS that results from unrestrained human herpesvirus 8 infection. It can have an atypical presentation and an aggressive clinical course in patients with uncontrolled HIV infection. We present an interesting case of AIDS-related KS with an atypical initial presentation with skin nodules and debilitating lymphoedema. Patient was successfully managed with supportive measures, antiretroviral therapy and systemic chemotherapy.
Multiple Oral Kaposi ́S Sarcomas Associated With Acquired Immunodeficiency Syndrome - Case Report.

Ana Luiza Carias de Oliveira CORRÊA,Camila Paloma PINTO,Melissa Rodrigues ARAÚJO,Maria Ângela Naval MACHADO,Antonio Adilson Soares de LIMA

DOI: https://doi.org/10.1016/j.oooo.2023.12.535

2024-06-07

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Abstract:Kaposi's sarcoma (KS) is an angioproliferative neoplasm caused by human herpesvirus 8 that affects mucocutaneous tissues and aero-digestive tracts. KS typically exhibits an aggressive course and has a poor prognosis in individuals with AIDS. The aim of this study is to present a case of disseminated KS. An adult white male was hospitalized due to complications arising from AIDS. Clinical examination revealed the presence of multiple bluish-purple nodules on the hard palate and tongue. Additionally, purplish papular lesions were observed on the skin of the lower and upper limbs as well as on the face.

dentistry, oral surgery & medicine
Vascular Conjunctival Lesion in a Patient With a Recent Diagnosis of HIV Infection

Sofia De Arrigunaga,Jason Fan,Carol L. Karp

DOI: https://doi.org/10.1001/jamaophthalmol.2023.6652

IF: 8.253

2024-07-19

JAMA Ophthalmology

Abstract:A young patient, diagnosed with HIV infection 5 months before presentation and taking highly active antiretroviral therapy (HAART), presented with a left eye lesion. At diagnosis, the CD4+ count was 69 cells/mm 3 . Examination revealed a highly vascular, superonasal heterogeneous mass with associated hemorrhage (Figure, A). High-resolution optical coherence tomography showed a subepithelial, hyperreflective, hypercellular tissue (Figure, B). The lesion was excised using the no-touch technique and cryotherapy. Histopathology revealed spindle-shaped cells positive for Human herpesvirus 8 stain (Figure, B, inset). Conjunctival Kaposi sarcoma (KS) lesions are usually red, dark brown, or violaceous; flat or elevated; and may be associated with subconjunctival hemorrhage. 1 ,2 Localized KS lesions can be treated with surgical excision. 1 In patients who are positive for HIV infection, HAART can be used as sole treatment 3 or in combination with interferon injections 4 or chemotherapeutic agents. 5 Ocular KS lesions have become uncommon amid the widespread use of HAART. 6

ophthalmology
Gastrointestinal Kaposi Sarcoma without Dermatological Lesions: A Case Report

Michael Imeh,Jorge O Gutierrez,Rinku Bhatija,Saher Shiza,Brian A Murillo,Ryan Lubarsky,Rajan Khanna

DOI: https://doi.org/10.12659/AJCR.941815

2023-12-07

Abstract:BACKGROUND Kaposi sarcoma is a malignancy of the vascular endothelium. It is associated with human herpesvirus 8 (HHV-8) infection, typically found with HIV/AIDS. It is rarely seen presenting as visceral involvement without any cutaneous lesions. Few case reports have described this. CASE REPORT We report a case of visceral Kaposi sarcoma (specifically, gastrointestinal lesions) without any cutaneous lesions in a 35-year-old man with HIV/AIDS who presented with abdominal pain, fatigue, and melena of a 15-day duration. Physical examination revealed tachycardia and hypertension, with a negative orthostatic sign. There were no visible signs of bleeding or cutaneous lesions, no abdominal pain, and a digital rectal examination was negative. Laboratory test results were significant for severe microcytic anemia, with hemoglobin level of 3.3 g/dL, decreased ferritin and iron levels, high red cell distribution width, and reticulocyte index lower than appropriate for anemia level. The absolute CD4 count was 33/uL, and the viral load was 56 895 copies/mL. Hemoglobin was optimized with packed red cells prior to endoscopy, and Pneumocystis jirovecii pneumonia prophylaxis was started. Esophagogastroduodenoscopy and colonoscopy revealed small and large bowel hemorrhagic stellate and annular lesions of varying sizes. Pathology reports from biopsy of the lesions seen in the procedure reported Kaposi sarcoma positive for HHV-8. He underwent chemotherapy with doxorubicin and showed clinical and laboratory improvement after treatment. CONCLUSIONS Kaposi sarcoma should be considered and investigated in patients with HIV/AIDS who are not on highly active antiretroviral therapy and present with gastrointestinal bleeding as an initial symptom, without any cutaneous lesions.
Disseminated Kaposi Sarcoma: Case Report.

Isabela DAMBISKI,Cecília Valesti OLIVEIRA,José Miguel AMENABAR,Cassius Carvalho TORRES-PEREIRA,Heliton Gustavo de LIMA,Juliana Lucena SCHUSSEL,Melissa Rodrigues de ARAUJO

DOI: https://doi.org/10.1016/j.oooo.2023.12.325

2024-06-07

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Abstract:AIDS-associated disseminated Kaposi's Sarcoma is the most common HIV-associated neoplasm, caused by the human herpes virus 8. It is rare, has a rapid, progressive, and highly fatal course if left untreated. This condition primarily affects the skin and mucous membranes. A 25-year-old man was diagnosed with HIV/AIDS four months before the onset of the skin lesions. He has been on antiretroviral therapy since his diagnosis. At the time of hospital admission, he presented with an elevated viral load, a low CD4 count, and kidney and liver dysfunction.

dentistry, oral surgery & medicine
Donor‐derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report

Russo Antonio,Giovannini Laura,Conti Nicolina,Sabattini Elena,Vizioli Luca,Lazzarotto Tiziana,Potena Luciano,Pacini Davide,Galie’ Nazzareno

DOI: https://doi.org/10.1111/tid.13609

2021-04-24

Transplant Infectious Disease

Abstract:<p>Human herpesvirus‐8 (HHV‐8) infection is associated with neoplastic and non‐neoplastic diseases in immunocompromised patients. Kaposi sarcoma (KS) is a common malignancy reported in solid organ transplant recipients (SOTR). Kaposi sarcoma inflammatory cytokine syndrome (KICS), initially described in HIV patients, is characterized by high viral loads, elevated levels of cytokines, cytopenia, high fever, organ failure and poor outcome. We report the case of a 54‐year‐old patient who developed simultaneous occurrence of KS of lymph nodes and KICS as a complication of primary donor‐transmitted HHV‐8 infection, after heart transplantation (HT). The diagnosis, management and prognosis of this condition is unclear and needs a multidisciplinary approach.</p>

immunology,infectious diseases,transplantation
Iatrogenic Kaposi’s Sarcoma in an HIV-Negative Young Male With Crohn’s Disease and IgA Nephropathy: A Case Report and Brief Review of the Literature

Annika L. Windon,Stuti G. Shroff

DOI: https://doi.org/10.1177/1066896917736610

2017-11-23

International Journal of Surgical Pathology

Abstract:BACKGROUND: Kaposi's sarcoma (KS) is a vascular tumor arising in association with human herpesvirus-8 (HHV-8) infection, and different variants show different clinical presentations. Isolated intestinal KS in the background of Crohn's disease (CD) is exceedingly rare with only 3 cases reported in the English literature (from 1966 to 2016).CASE PRESENTATION: Herein, we report a case of intestinal KS in a 21-year-old HIV-negative Ethiopian male with a long-standing history of steroid therapy for his underlying IgA nephropathy. Recent gastrointestinal biopsies confirmed an additional diagnosis of CD. Despite the addition of Infliximab to his therapy, his CD remained refractory, and a laparoscopic-assisted ileocolectomy was performed to alleviate a partial small bowel obstruction. Examination of his terminal ileum demonstrated a polypoid mass with adjacent incidental ileal submucosal nodules. These nodules were composed of plump spindle cells with scattered mitoses and vascular channels with extravasated red blood cells. Intratumoral hyaline globules were also noted. Immunohistochemistry revealed HHV-8 positivity, confirming the histologic impression of KS.CONCLUSIONS: Here we report the fourth case of KS in CD in an HIV-negative patient and only the third case of isolated intestinal KS in the setting of CD. A review of the literature suggests that attenuation of immunosuppressive therapy may be adequate management of iatrogenic KS in the absence of a systemic HHV-8 infection.

pathology,surgery
Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.

Shasha Li,Lei Bai,Jiazhen Dong,Rui Sun,Ke Lan

DOI: https://doi.org/10.1007/978-981-10-5765-6_7

2017-01-01

Advances in experimental medicine and biology

Abstract:Kaposi's sarcoma-associated herpesvirus (KSHV), also known as Human herpesvirus 8 (HHV-8), is a member of the lymphotropic gammaherpesvirus subfamily and a human oncogenic virus. Since its discovery in AIDS-associated KS tissues by Drs. Yuan Chang and Patrick Moore, much progress has been made in the past two decades. There are four types of KS including classic KS, endemic KS, immunosuppressive therapy-related KS, and AIDS-associated KS. In addition to KS, KSHV is also involved in the development of primary effusion lymphoma (PEL) and certain types of multicentric Castleman's disease. KSHV manipulates numerous viral proteins to promote the progression of angiogenesis and tumorigenesis. In this chapter, we review the epidemiology and molecular biology of KSHV and the mechanisms underlying KSHV-induced diseases.
Kaposi Sarcoma Associated With Iatrogenic Immunosuppression: A Rare Complication of Bullous Pemphigoid Treatment

Catherine Tremblay,Dominique Friedmann

DOI: https://doi.org/10.1177/1203475417712247

Abstract:Background: Bullous pemphigoid (BP) is an autoimmune bullous disease requiring immunosuppressive therapy. Kaposi sarcoma (KS) is an angioproliferative tumor associated with the opportunistic viral infection human herpes virus 8 (HHV-8). It is a well-known condition associated with longstanding human immunodeficiency virus infection, but it may also occur in the context of iatrogenic immunosuppression. Objective: Although a rare complication, all dermatologists dealing with immunosuppressors must be aware and have a high index of suspicion when a patient presents with rapidly progressive violaceous papules. Methods and results: We describe an Italian male patient treated for bullous pemphigoid with topical and systemic corticosteroids and mycophenolate mofetil (MMF) who developed multifocal cutaneous KS after a few months of therapy. Conclusion: To our knowledge, KS onset associated with MMF and corticosteroids intake for BP treatment has not been reported previously. KS associated with iatrogenic immunosuppression can have an aggressive course, and it must be promptly recognised since cessation of immunosuppression therapy can lead to complete resolution. Immune restoration is the key to control this viral infection.

Cutaneous Kaposi's Sarcoma

Kaposi’s Sarcoma Manifested As Lower Gastrointestinal Bleeding in a HIV/HBV-co-infected Liver Cirrhosis Patient: A Case Report

Vaccine prospect of Kaposi sarcoma-associated herpesvirus.

[Kaposi's disease: an unusual side-effect of topical corticosteroids]

Kaposi Sarcoma Combined with Severe Ulcerative Colitis: A Case Report and Literature Review

Sign of Leser-Trélat Associated with Kaposi Sar-coma in an Immunocompetent Man

Pulmonary Kaposi Sarcoma in the Era of Antiretroviral Therapy: A Case Series

Endoscopic Appearance of Oropharyngeal and Upper GI Kaposi's Sarcoma in an Immunocompromised Patient

Kaposi's sarcoma and its associated herpesvirus

Kaposi Sarcoma after Kidney Transplantation: a Case Report and Literature Review

Classic Kaposi Sarcoma in an Immunocompetent Male From Haiti: An Unusual Epidemiological Presentation

Hiv Diagnosis Due To Kaposi ́S Sarcoma Lesion In The Oral Cavity: Case Report.

Skin nodules in a young patient with HIV/AIDS

Multiple Oral Kaposi ́S Sarcomas Associated With Acquired Immunodeficiency Syndrome - Case Report.

Vascular Conjunctival Lesion in a Patient With a Recent Diagnosis of HIV Infection

Gastrointestinal Kaposi Sarcoma without Dermatological Lesions: A Case Report

Disseminated Kaposi Sarcoma: Case Report.

Donor‐derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report

Iatrogenic Kaposi’s Sarcoma in an HIV-Negative Young Male With Crohn’s Disease and IgA Nephropathy: A Case Report and Brief Review of the Literature

Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.

Kaposi Sarcoma Associated With Iatrogenic Immunosuppression: A Rare Complication of Bullous Pemphigoid Treatment